Dongsheng Zhang - Search Results

Year	Number of Results
1999	1
2000	1
2002	7
2003	6
2004	7
2005	6
2006	10
2007	14
2008	9
2009	12
2010	12
2011	25
2012	23
2013	30
2014	39
2015	35
2016	41
2017	34
2018	35
2019	44
2020	43
2021	52
2022	58
2023	47
2024	21

1

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, Li Y, Li F, Zhang C, Zhang D, Zhang H, Huang H, Chen X, Wang YA, Lin C, Liu G, Song L, Liao W. Shi D, et al. Among authors: zhang d. Nat Commun. 2022 Sep 26;13(1):5644. doi: 10.1038/s41467-022-33285-x. Nat Commun. 2022. PMID: 36163134 Free PMC article.

2

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac⁴C acetylation of KIF23 mRNA.

Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, Tan Y, Ji J, Chen Z, Sun Q, Yang S, Tang J, Feng Y, Sun Y. Jin C, et al. Among authors: zhang d. J Exp Clin Cancer Res. 2022 Dec 15;41(1):345. doi: 10.1186/s13046-022-02551-7. J Exp Clin Cancer Res. 2022. PMID: 36522719 Free PMC article.

3

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.

Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Yang E, et al. Among authors: zhang d. Signal Transduct Target Ther. 2020 Oct 19;5(1):242. doi: 10.1038/s41392-020-00359-5. Signal Transduct Target Ther. 2020. PMID: 33077737 Free PMC article. Review.

4

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, Lv ZD, Wang DS, Li YH, Zhang DS, Xu RH. Wang F, et al. Cell Rep Med. 2021 Aug 27;2(9):100383. doi: 10.1016/j.xcrm.2021.100383. eCollection 2021 Sep 21. Cell Rep Med. 2021. PMID: 34622226 Free PMC article. Clinical Trial.

5

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Wang F, He MM, Xiao J, Zhang YQ, Yuan XL, Fang WJ, Zhang Y, Wang W, Hu XH, Ma ZG, Yao YC, Zhuang ZX, Zhou FX, Ying JE, Yuan Y, Zou QF, Guo ZQ, Wu XY, Jin Y, Mai ZJ, Wang ZQ, Qiu H, Guo Y, Shi SM, Chen SZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. Wang F, et al. Clin Cancer Res. 2022 Oct 3;28(19):4232-4239. doi: 10.1158/1078-0432.CCR-22-0655. Clin Cancer Res. 2022. PMID: 35929990 Free PMC article. Clinical Trial.

6

The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.

Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, Song K, Xu RH. Chen DL, et al. Mol Cancer. 2021 Dec 15;20(1):166. doi: 10.1186/s12943-021-01475-8. Mol Cancer. 2021. PMID: 34911533 Free PMC article.

7

OTUB1 Catalytic-Independently Deubiquitinates TGFBI and Mediates the Angiogenesis in Infantile Hemangioma by Regulating Glycolysis.

Li M, Wang X, Yang E, Li Y, Geng Y, Chen Z, Huang S, Zhang D, Wu H. Li M, et al. Among authors: zhang d. Arterioscler Thromb Vasc Biol. 2023 May;43(5):654-673. doi: 10.1161/ATVBAHA.123.319177. Epub 2023 Mar 30. Arterioscler Thromb Vasc Biol. 2023. PMID: 36994729

8

Promotion of colorectal cancer progression by immune-related lnc-SOX9-4 via suppression of YBX1 poly-ubiquitination and degradation.

Zhao Y, Yang S, Nie H, Zhang D, Wang T, Sun Q, Wang X, Sun Y. Zhao Y, et al. Among authors: zhang d. Cell Signal. 2023 Nov;111:110854. doi: 10.1016/j.cellsig.2023.110854. Epub 2023 Aug 22. Cell Signal. 2023. PMID: 37611648 Free article.

9

Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia.

Zhang D, Tang W, Niu H, Tse W, Ruan HB, Dolznig H, Knösel T, Karl-Heinz F, Themanns M, Wang J, Song M, Denson L, Kenner L, Moriggl R, Zheng Y, Han X. Zhang D, et al. Genes Dis. 2023 Jan 2;11(1):413-429. doi: 10.1016/j.gendis.2022.11.024. eCollection 2024 Jan. Genes Dis. 2023. PMID: 37588188 Free PMC article.

10

Super-resolution wearable electrotactile rendering system.

Lin W, Zhang D, Lee WW, Li X, Hong Y, Pan Q, Zhang R, Peng G, Tan HZ, Zhang Z, Wei L, Yang Z. Lin W, et al. Among authors: zhang d. Sci Adv. 2022 Sep 9;8(36):eabp8738. doi: 10.1126/sciadv.abp8738. Epub 2022 Sep 9. Sci Adv. 2022. PMID: 36083898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

546 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

546 results

Results by year